Tysabri (Natalizumab) Receives Approval in European Union for ...

DG News - USA
... 29, 2006 -- Biogen Idec and Elan Corporation, plc today announced that they received approval from the European Commission to market Tysabri® (natalizumab) as ...

Biogen And Elan Receive European Commission's Approval To Market ...
Trading Markets - Los Angeles,CA,USA
... PowerRating) and Elan Corp., plc (ELN | charts | news | PowerRating) revealed that they received approval from the European Commission to market TYSABRI as a ...

UPDATE 1-Elan, Biogen get European approval for Tysabri
Reuters - USA
... BIIB.O: Quote, Profile, Research) said on Thursday they had received European Commission approval to market multiple sclerosis treatment Tysabri, which was ...

European Commission gives approval to Elan's Tysabri MS drug
FinFacts Ireland - Ireland
... Idec and Irish drugs firm Elan Corporation, plc today announced that they received approval from the European Commission to market TYSABRI (natalizumab) as a ...

Elan's Tysabri back on Irish shelves by July
RTE.ie - Ireland
Elan says this morning that it has received approval from the European Commission to bring back its suspended multiple sclerosis drug Tysabri. ...

CORRECTION Elan, Biogen's MS drug Tysabri gets EU marketing go ...
Life Style Extra - UK
LONDON (AFX) - Elan Corp and Biogen Idec's Tysabri has received European marketing approval as a treatment for relapsing remitting multiple sclerosis, to delay ...

EU Approves Sale of MS Drug Tysabri
CBS News - USA
By SHAWN POGATCHNIK Associated Press Writer. (AP) The US and Irish makers of Tysabri, a highly touted drug used to suppress the effects of multiple sclerosis ...